Health TrialsbyHealthPanel

Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis (EUS-CPN) for Chronic Pancreatitis

ConditionChronic Pancreatitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIndiana University

About this trial

Physicians need a tracking system for specific treatment modalities, and data to determine the impact of endoscopic ultrasound pain management for patients with chronic pancreatitis.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years of age or older

Referral for the treatment of pain related to chronic pancreatitis

Disqualifiers

Less than 18 years of age

Absence of chronic pancreatitis

Trial population

As long as patients fall under the inclusion criteria and do not fall under exclusions, every patient can be considered. Patient must be declared safe to undergo procedure on individual basis from an evaluation from head doctor on study.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Celiac Plexus Neurolysis

    Procedure/Surgery

    When CPBs are not effective (less than one month of relief) then a Celiac Plexus Neurolysis may be completed to manage pain associated with Chronic Pancreatitis.

Treatment groups

35 Participants
are divided into 1 treatment group
Group A: Chronic Pancreatitis Patients1 intervention

Trial outcomes

Primary outcomes

1

Use of Pain medication

Use of pain medication (by using morphine equivalents) for each patient will be tracked weekly for up to 24 weeks post CPN to track pain management/relief for the of patients. There should be a lessening in use of pain medication as time progesses.

Time frame
Immediately post procedure & weekly up to 24 weeks
2

Patient's pain intensity score (numeric pain rating scale using the visual analogue scale VAS from 1-10) will be assessed weekly (via phone call follow ups) starting right after CPN and continuing for 24 weeks.

Compare weekly pain intensity score for pain management/relief of patients.

Time frame
Immediately post procedure and weekly up to 24 weeks
3

Dosage of pain medication

Compare dose of pain medication post procedure \& weekly for up to 24 weeks after converting all to morphine equivalents

Time frame
Immediately post procedure and weekly up to 24 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Indiana University

Lead sponsor

Source ClinicalTrials.gov
Apply now